These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 18813708

  • 21. The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.
    Pihut M, Ferendiuk E, Szewczyk M, Kasprzyk K, Wieckiewicz M.
    J Headache Pain; 2016; 17():29. PubMed ID: 27011213
    [Abstract] [Full Text] [Related]

  • 22. Botulinum toxin for trigeminal neuralgia.
    Nurmikko T, Cruccu G.
    Eur J Neurol; 2009 May; 16(5):e104. PubMed ID: 19405205
    [No Abstract] [Full Text] [Related]

  • 23. Botulinum Toxin Type A for the Treatment of Auriculotemporal Neuralgia-A Case Series.
    Tereshko Y, Belgrado E, Lettieri C, Gigli GL, Valente M.
    Toxins (Basel); 2023 Apr 06; 15(4):. PubMed ID: 37104212
    [Abstract] [Full Text] [Related]

  • 24. Intramuscular injection of botulinum toxin as an adjunct to arthrocentesis of the temporomandibular joint: preliminary observations.
    Freund BJ, Schwartz M.
    Br J Oral Maxillofac Surg; 2003 Oct 06; 41(5):351-2. PubMed ID: 14581034
    [No Abstract] [Full Text] [Related]

  • 25. Head and neck muscle spasm after radiotherapy: management with botulinum toxin A injection.
    Van Daele DJ, Finnegan EM, Rodnitzky RL, Zhen W, McCulloch TM, Hoffman HT.
    Arch Otolaryngol Head Neck Surg; 2002 Aug 06; 128(8):956-9. PubMed ID: 12162778
    [Abstract] [Full Text] [Related]

  • 26. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial.
    Wu CJ, Lian YJ, Zheng YK, Zhang HF, Chen Y, Xie NC, Wang LJ.
    Cephalalgia; 2012 Apr 06; 32(6):443-50. PubMed ID: 22492424
    [Abstract] [Full Text] [Related]

  • 27. Injection of botulinum toxin type A (BOTOX) into trigger zone of trigeminal neuralgia as a means to control pain.
    Ngeow WC, Nair R.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar 06; 109(3):e47-50. PubMed ID: 20219585
    [Abstract] [Full Text] [Related]

  • 28. Myofascial pain of the jaw muscles: comparison of short-term effectiveness of botulinum toxin injections and fascial manipulation technique.
    Guarda-Nardini L, Stecco A, Stecco C, Masiero S, Manfredini D.
    Cranio; 2012 Apr 06; 30(2):95-102. PubMed ID: 22606852
    [Abstract] [Full Text] [Related]

  • 29. Botulinum toxin-A as a treatment option for refractory idiopathic trigeminal neuralgia of the ophthalmic branch: a case report and literature review.
    Kandari A, Devaprasad BATP, Hernandez-Rivera P, Hernandez IA, Friesen R.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 May 06; 137(5):e73-e82. PubMed ID: 38575452
    [Abstract] [Full Text] [Related]

  • 30. Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial.
    Marco E, Duarte E, Vila J, Tejero M, Guillen A, Boza R, Escalada F, Espadaler JM.
    J Rehabil Med; 2007 Jul 06; 39(6):440-7. PubMed ID: 17624477
    [Abstract] [Full Text] [Related]

  • 31. A new treatment paradigm for trigeminal neuralgia using Botulinum toxin type A.
    Guardiani E, Sadoughi B, Blitzer A, Sirois D.
    Laryngoscope; 2014 Feb 06; 124(2):413-7. PubMed ID: 23818108
    [Abstract] [Full Text] [Related]

  • 32. The Therapeutic Effect of Botulinum Toxin Type A on Trigeminal Neuralgia: Are There Any Differences between Type 1 versus Type 2 Trigeminal Neuralgia?
    Tereshko Y, Valente M, Belgrado E, Dalla Torre C, Dal Bello S, Merlino G, Gigli GL, Lettieri C.
    Toxins (Basel); 2023 Nov 14; 15(11):. PubMed ID: 37999517
    [Abstract] [Full Text] [Related]

  • 33. Increasing relief with repeated botulinum neurotoxin A injections in a rare case of hemi facial spasm with contralateral trigeminal autonomic orofacial pain and occipital neuralgia: A case report.
    Punj J, Singh P.
    Toxicon; 2023 Jun 01; 228():107120. PubMed ID: 37031873
    [Abstract] [Full Text] [Related]

  • 34. Intraoral administration of botulinum toxin for trigeminal neuropathic pain.
    Herrero Babiloni A, Kapos FP, Nixdorf DR.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Jun 01; 121(6):e148-53. PubMed ID: 27181448
    [Abstract] [Full Text] [Related]

  • 35. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study.
    Sidebottom AJ, Patel AA, Amin J.
    Br J Oral Maxillofac Surg; 2013 Apr 01; 51(3):199-205. PubMed ID: 22871559
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
    Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G.
    Cranio; 2008 Apr 01; 26(2):126-35. PubMed ID: 18468272
    [Abstract] [Full Text] [Related]

  • 37. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome.
    Wheeler AH, Goolkasian P, Gretz SS.
    Spine (Phila Pa 1976); 1998 Aug 01; 23(15):1662-6; discussion 1667. PubMed ID: 9704373
    [Abstract] [Full Text] [Related]

  • 38. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity.
    von Lindern JJ, Niederhagen B, Bergé S, Appel T.
    J Oral Maxillofac Surg; 2003 Jul 01; 61(7):774-8. PubMed ID: 12856249
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and Safety of Botulinum Toxin Type A in Treating Patients of Advanced Age with Idiopathic Trigeminal Neuralgia.
    Liu J, Xu YY, Zhang QL, Luo WF.
    Pain Res Manag; 2018 Jul 01; 2018():7365148. PubMed ID: 29849847
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of botulinum toxin type A treatment of functional impairment of degenerative hip joint: Preliminary results.
    Marchini C, Acler M, Bolognari MA, Causero A, Volpe D, Regis D, Rizzo A, Rosa R, Eleopra R, Manganotti P.
    J Rehabil Med; 2010 Jul 01; 42(7):691-3. PubMed ID: 20603701
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.